Serial entrepreneur with one successful exit. Building a huge passion project, a global veterinary and pet brand on the heels of eight years of success in human cannabinoid science. Now working with top scientists at Weizmann Institute to roll out very important science breakthroughs into the livestock market. Our company is aiming to merge cannabinoid medicine and pharmaceutical led clinical trials and disrupt the pharma industry.

Maven Bioscience is transforming the future of cannabinoid medicine through differentiated products and government approvals.